ImportRefusal LogoImportRefusal

NIPRO RENAL SOLUTIONS SPAIN S.R.

⚠️ High Risk

FEI: 3012687521 • Mollerussa, Lleida • SPAIN

FEI

FEI Number

3012687521

📍

Location

Mollerussa, Lleida

🇪🇸

Country

SPAIN
🏢

Address

Avinguda Negrals 1, , Mollerussa, Lleida, Spain

High Risk

FDA Import Risk Assessment

59.3
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

24
Total Refusals
5
Unique Violations
3/6/2025
Latest Refusal
10/14/2016
Earliest Refusal

Score Breakdown

Violation Severity
60.9×40%
Refusal Volume
51.8×30%
Recency
82.6×20%
Frequency
28.6×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

50812×

NO 510(K)

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.

11810×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

32805×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

27804×

DEVICEGMPS

The article is subject to refusal of admission pursuant to Section 801(a)(1) in that the methods used in, or the facilities or controls used for, the manufacture, packing, storage, or installation of the device do not conform to the requirements of Section 520(f)(1) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) or a condition prescribed by an order under section 520(f)(2) of the FD&C Act.

2371×

NO PMA

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the device appears to be a Class III device and does not appear to have in effect an approved application for premarket approval pursuant to Section 515 of the Act, or an exemption pursuant to Section 520(g)(1).

Refusal History

DateProductViolationsDivision
3/6/2025
78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
508NO 510(K)
Division of Southeast Imports (DSEI)
12/3/2024
78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
508NO 510(K)
Division of Southeast Imports (DSEI)
8/28/2024
78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
118NOT LISTED
Division of Southeast Imports (DSEI)
8/6/2024
78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
508NO 510(K)
Division of Southeast Imports (DSEI)
7/8/2024
78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
2780DEVICEGMPS
Division of Southeast Imports (DSEI)
5/10/2023
78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
2780DEVICEGMPS
Division of Southeast Imports (DSEI)
5/8/2023
78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
118NOT LISTED
3280FRNMFGREG
Division of Southeast Imports (DSEI)
3/28/2023
78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
508NO 510(K)
Division of Southeast Imports (DSEI)
2/13/2023
78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
2780DEVICEGMPS
Division of Southeast Imports (DSEI)
2/13/2023
78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
2780DEVICEGMPS
Division of Southeast Imports (DSEI)
1/17/2023
78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
508NO 510(K)
Division of Southeast Imports (DSEI)
1/17/2023
78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
508NO 510(K)
Division of Southeast Imports (DSEI)
12/15/2022
78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
508NO 510(K)
Division of Southeast Imports (DSEI)
6/14/2022
78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
237NO PMA
Division of Southeast Imports (DSEI)
1/11/2022
78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
118NOT LISTED
Division of Southeast Imports (DSEI)
12/29/2021
78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
508NO 510(K)
Division of Southeast Imports (DSEI)
8/12/2021
78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
118NOT LISTED
3280FRNMFGREG
508NO 510(K)
Division of Southeast Imports (DSEI)
3/25/2021
78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
118NOT LISTED
3280FRNMFGREG
Division of Southeast Imports (DSEI)
3/2/2021
78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
118NOT LISTED
3280FRNMFGREG
508NO 510(K)
Division of Southeast Imports (DSEI)
11/9/2020
78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
118NOT LISTED
Division of Southeast Imports (DSEI)
7/24/2020
78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
118NOT LISTED
Division of Southeast Imports (DSEI)
5/16/2020
78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
118NOT LISTED
Division of Southeast Imports (DSEI)
4/13/2020
78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
508NO 510(K)
Division of Southeast Imports (DSEI)
10/14/2016
78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
118NOT LISTED
3280FRNMFGREG
508NO 510(K)
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is NIPRO RENAL SOLUTIONS SPAIN S.R.'s FDA import refusal history?

NIPRO RENAL SOLUTIONS SPAIN S.R. (FEI: 3012687521) has 24 FDA import refusal record(s) in our database, spanning from 10/14/2016 to 3/6/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. NIPRO RENAL SOLUTIONS SPAIN S.R.'s FEI number is 3012687521.

What types of violations has NIPRO RENAL SOLUTIONS SPAIN S.R. received?

NIPRO RENAL SOLUTIONS SPAIN S.R. has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about NIPRO RENAL SOLUTIONS SPAIN S.R. come from?

All FDA import refusal data for NIPRO RENAL SOLUTIONS SPAIN S.R. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.